Page 38 - Markets

Kaynes Technology crashes 13%, hits eight-month low; brokerages cautious

In the past one month, Kaynes Tech stock has tanked 31 per cent as compared to 2.3 per cent rise in the BSE Sensex

Stock Market close: Sensex jumps 447 pts, Nifty at 26,186 as investors cheer RBI rate cut

Sensex Today | Stock Market close, Dec 5, 2025: In the broader markets, the Nifty MidCap index gained 0.49 per cent, and the Nifty SmallCap index dropped 0.57 per cent

Last day to bid for Vidya Wires IPO: Check subscription status, GMP

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

IPO Calendar: D-Street braces for 9 new issues; Meesho, Aequs listings

IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore

Gold trades in a tight band with constructive bias; dip buying favoured

The yellow metal, at the time of writing this article, was trading at $4,213, up nearly 0.2 per cent for the day, even as the US yields firmed up

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Motilal Oswal retains 'Buy' on JSW Infra as FY30 growth roadmap strengthens

With a balanced east-west coast presence and expanding inland logistics capabilities, JSWINFRA, analysts believe, is well-placed to benefit from India's push for multimodal integration

Hero MotoCorp accelerates on EV surge, rural push, says Nirmal Bang; 'Buy'

The brokerage turn incrementally constructive on Hero given improving domestic share trends, rural demand tailwinds, strengthening EV ramp-up, and strong export momentum

Stocks to Watch today, Dec 5: IndiGo, banks, auto, ITC Hotels, Adani Ent

Stocks to Watch, Friday, Dec 5: Rate sensitive stocks, RailTel, Samvardhana Motherson, IndusInd Bank, Deepak Nitrite, and Tata Power are some other stocks to watch today

Avoid exiting Balanced Advantage Funds based on short-term underperformance

Balanced Advantage Funds have had a weak year, but advisors warn against knee-jerk exits, saying investors should stay invested unless a fund persistently lags peers and benchmarks

JM Financial starts coverage on KPR Mill with 'Buy'; check target price

JM Financial has set a target price of ₹1,215 per share, implying an upside potential of 21 per cent

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Mphasis up 2% on innovation program update; PL Capital upgrades to 'Buy'

Domestic brokerage PL Capital has upgraded its rating on Mphasis shares to 'Buy' from 'Accumulate', with a revised target price of ₹3,310 per share

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Here's why Adani Enterprises share price rose 2% in trade on December 4

Adani Enterprises informed the exchanges that AdaniConneX Private Limited, a joint venture of the company, has incorporated a wholly owned subsidiary (WOS) namely 'AdaniConneX Hyderabad Three Limited'

DIC India shares gain 5% after Karnataka GST authorities slash penalty

The upward movement in DIC India's share price came after the Karnataka GST department revised the total GST demand against the company to ₹3.81 lakh from ₹6.71 crore

Nephrocare Health sets IPO price band at ₹438-460: Check key details here

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Motilal Oswal retains 'Buy' on Aurobindo Pharma as FY26-28 prospects shine

Tushar Manudhane, Vipul Mehta, and Eshita Jain, research analysts at MOFSL, value Aurobindo Pharma at 16 times 12-month forward earnings, assigning a target price of ₹1,430